Clinical Trials Sponsored by Starx Research Center, LLC

Total 320 results

Starx Research Center, LLC

Unknown

Ocular Allergy Treatment Practical Impact Trial ((OAT-PIT))

Allergic Conjunctivitis | Rhinoconjunctivitis

United States
Research Center, LLC

Completed

Clinical Evaluation of Effectiveness and Safety of Dietary Supplement Potensa in Men With Erectile Dysfunction

Erectile Dysfunction

Russian Federation
Sarcoma Oncology Research Center, LLC

Recruiting

Evaluation of Autologous Natural Killer Cell Activity in Primary Cancer Cell Cultures

Sarcoma

United States
Sarcoma Oncology Research Center, LLC

Recruiting

GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma

Sarcoma

United States
Sarcoma Oncology Research Center, LLC

Recruiting

Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma (TNT)

Sarcoma

United States
Perseverance Research Center, LLC
HDC

Completed

Effectiveness of a Real Time Data Safety Study Tool (RTD)

Study Subjects Currently Enrolled in a Clinical Research Trial

United States
Sarcoma Oncology Research Center, LLC

Recruiting

Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma (TAGGED)

Leiomyosarcoma

United States
Altria Client Services LLC
Rose Research Center, LLC

Recruiting

Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART

Cigarette Smoking Behavior

United States
Sarcoma Oncology Research Center, LLC
Advenchen Laboratories, LLC

Active, not recruiting

Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors

Soft Tissue Sarcoma | Small Cell Lung Cancer | Non Small Cell Lung Cancer | Solid Tumor, Adult

United States
EDDC (Experimental Drug Development Centre), A*STAR...
Parexel

Recruiting

A Study of EBC-129 in Advanced Solid Tumours

Advanced Solid Tumours

United States, Singapore
EDDC (Experimental Drug Development Centre), A*STAR...
PPD

Active, not recruiting

A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours

Solid Tumors

United States, Singapore
Friends Research Institute, Inc.
Rose Research Center, LLC

Completed

Pharmacokinetics of Nicotine Sublingual Tablets Versus Nicorette Lozenge in Healthy Smokers

Tobacco Use Disorder | Cigarette Smoking

United States
DeNova Research
Mentor Worldwide, LLC

Completed

Safety and Efficacy Study of Polydioxanone (PDS) Plates in Rhinoplasty

Rhinoplasty

United States
Pfizer
Roswell Park Cancer Institute; South Texas Accelerated Research Therapeutics...

Completed

A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients

Advanced Malignant Solid Tumors

United States
AOBiome LLC
Integrium; Orange County Research Center

Completed

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis

Allergic Rhinitis Due to Grass Pollen | Allergic Rhinitis | Healthy Volunteers

United States, Canada
Center for Ophthalmic and Vision Research, LLC

Completed

OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers

Dry Eye

United States
Juul Labs, Inc.
Rose Research Center, LLC

Completed

A Study to Characterize Puff Topography With Use of JUUL 5% Electronic Nicotine Delivery Systems (ENDS) in Adult Smokers

Tobacco Use | Tobacco Smoking | Nicotine Dependence, Other Tobacco Product

United States
Perseverance Research Center, LLC
Athena Medical Group

Unknown

Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 (COVID-19)

COVID-19

United States
Pennington Biomedical Research Center
Quest Nutrition LLC

Withdrawn

The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion (FAT ABSORBER)

Obesity | Cardiovascular Disease

United States
Tennessee Clinical Research Center
Graceway Pharmaceuticals, LLC

Terminated

Treatment of Actinic Keratoses of the Face With Imiquimod 3.75% Cream Followed by Photodynamic Therapy

Actinic Keratosis

United States
Heart Center Research, LLC
Boston Scientific Corporation

Recruiting

Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts (DART-HA)

Heart Failure, Congestive

United States
Genuine Research Center, Egypt
Hikma Pharmaceuticals LLC

Completed

Bioequivalence Study of Budesonide From Ekmasonid 9 mg Extended Release FCT (Hikma Pharma, Egypt) Versus Uceris 9 mg Extended Release Tablets (Man. for: Salix Pharm., a Division of Valeant Pharm. LLC, USA, by: Cosmo S.P.A., Italy by License of Cosmo Tech. Ltd., Ireland, Product of France)

Healthy

Egypt
Federal State Budgetary Scientific Institution...
Federal Stare Budgetary Scientific Institution, Mental Health Research Center

Recruiting

Effects of Weight Loss Management on Cognitive Function in Elderly Women With Obesity

Obesity | Cognitive Change

Russian Federation
H. Lee Moffitt Cancer Center and Research Institute
Pharmacyclics LLC.

Completed

Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Carcinoid Tumors | Pancreatic NET

United States
Sarcoma Oncology Research Center, LLC
Tyme, Inc

Active, not recruiting

SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma (HopES)

Sarcoma | Sarcoma, Ewing

United States
Genuine Research Center, Egypt
Hikma Pharmaceuticals LLC

Completed

Bioequivalence Study of Fingolimod From Sphingomod 0.5 mg Hard Gelatin Capsules (Hikma Pharma, Egypt) Versus Gilenya 0.5 mg Hard Capsules (Novartis Pharma AG, Basle, Switzerland).

Healthy

Egypt
Cyclo Therapeutics, Inc.
Kerwin Research Center, LLC

No longer available

Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease

Late Onset Alzheimer Disease
EDDC (Experimental Drug Development Centre), A*STAR...
Chiltern International Inc.

Withdrawn

Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies

Ph+ Acute Lymphoblastic Leukemia (Ph+ALL) | Ph- Acute Lymphoblastic Leukemia (Ph-ALL) | Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+) | Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)

United States, Singapore
University Health Network, Toronto
Patient-Centered Outcomes Research Institute; M.D. Anderson Cancer Center; Applied... and other collaborators

Active, not recruiting

PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer (PRO-ACTIVE)

Dysphagia

United States, Canada
Pancreatic Cancer Research Team
Berg, LLC

Unknown

Project Survival-Prospective Biomarker Discovery

Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreatitis | Metastatic Pancreatic Cancer

United States
Lahore Medical Research Center, LLP

Completed

Diagnostic and Therapeutic Potential of Substance P/ NK1R Receptor in Primary Dysmenorrhea

Primary Dysmenorrhea

Pakistan
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Janssen Research & Development, LLC

Active, not recruiting

Daratumumab in Treating Patients With Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

Clear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Bladder Urothelial Carcinoma | Metastatic Kidney Carcinoma | Malignant Urinary System Neoplasm

United States
Florida Academic Centers Research and Education...

Not yet recruiting

Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa

Hidradenitis Suppurativa
Sarcoma Oncology Research Center, LLC
Bristol-Myers Squibb

Recruiting

SAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue Sarcoma

Advanced Soft Tissue Sarcoma | Metastatic Soft Tissue Sarcoma

United States
USDA, Western Human Nutrition Research Center
Sonomaceuticals LLC

Completed

Metabolic Response to Chardonnay Grape Marc Powder

Obesity | Dyslipidemia

United States
Bayer
Janssen Research & Development, LLC; Colorado Prevention Center

Completed

Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities (VOYAGER PAD)

Peripheral Artery Disease

Poland, Belgium, France, Spain, China, Korea, Republic of, United States, Switzerland, Estonia, Portugal, Japan, Hungary, Canada, Netherlands, Finland, Austria, United Kingdom, Germany, Czechia, Thailand, Brazil, Denmark, Italy, Russian... and more
Center for Biomedical Research, LLC
Provision Center for Proton Therapy

Recruiting

Registry Study for Proton Therapy Clinical Outcomes and Long-Term Follow-up (Registry)

Cancer

United States
Provision Center for Proton Therapy
Center for Biomedical Research, LLC

Recruiting

Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer

Prostate Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Minneamrita Therapeutics LLC

Terminated

Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Sarcoma Oncology Research Center, LLC
Aadi Bioscience, Inc.

Completed

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Melanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Ewing Sarcoma | Non Small Cell Lung Cancer | Chordoma | Urothelial Carcinoma | Classical Hodgkin Lymphoma | PEComa | Desmoid Tumor | Epithelioid Sarcoma | Squamous Cell Carcinoma | MTOR Activating Mutation

United States
ERLINDA M GORDON

Recruiting

LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma (LINNOVATE)

Advanced Soft-tissue Sarcoma

United States
National Research Center for Hematology, Russia
Enrollme.ru, LLC; Foundation for Cancer Research Support (RakFond)

Completed

Registry of Patients With Hematologic Disease and COVID-19 in Russia (CHRONOS19)

Coronavirus Infection and Hematologic Diseases

Russian Federation
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC; Janssen Scientific Affairs, LLC

Terminated

Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC; Janssen Scientific Affairs, LLC

Completed

Pembrolizumab in Combination With Ibrutinib for Advanced, Refractory Colorectal Cancers

Colorectal Cancer | Colon Cancer | Colorectal Carcinoma | Colon Disease

United States
LEC Eye Centre
Alcon Research

Completed

Visual Outcomes Following Bilateral Implantation of the Vivity Toric Intraocular Lens

Cataract Senile | Intraocular Lens Complication

Malaysia
Emory University
Bristol-Myers Squibb; Thrasher Research Fund; Sickle Cell Transplant Advocacy... and other collaborators

Active, not recruiting

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant (ASCENT)

Graft Versus Host Disease

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Recruiting

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

Ocular Melanoma | Uveal Melanoma

United States
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Recruiting

Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma

Merkel Cell Carcinoma | Neuroendocrine Carcinoma of the Skin | Trabecular Carcinoma of the Skin

United States
Kerry Rogers
Janssen Research & Development, LLC

Withdrawn

Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance

Chronic Lymphocytic Leukemia | Loss of Chromosome 17p
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC

Completed

Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

Melanoma

United States

Clinical Trials Sponsored by Starx Research Center, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Angola

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations